This is an in-person event, taking place in the Polani seminar room, CGTRM, 8th floor, Tower Wing, Guys Hospital. The speaker will be attending in-person, so please come along to the talk if you're available. No registration is required and everyone (internal or external to King's) is welcome!

Make sure you take advantage of this opportunity by attending as the talk won't be recorded.  

This is an in-person event only

* *

"Reducing Immunogenicity in Bile Duct Cellular Therapies"

Speaker: Dr Sandra Petrus-Reurer (University of Cambridge)

Biography: Sandra is originally from Menorca, Spain. She carried out her undergraduate studies in Biotechnology at University of Vic (Barcelona, Spain) and her Master’s degree in Cancer, Stem Cells and Developmental Biology at Utrecht University (Utrecht, the Netherlands). With main interest in cellular therapies for regenerative medicine, she carried out her doctoral studies at Karolinska Institute (Stockholm, Sweden) focused on the use of human embryonic stem cells for retinal repair in patients with age-related macular degeneration.

Sandra is currently a postdoctoral researcher at University of Cambridge (Cambridge, UK) and a Junior Research Fellow at Darwin College, where she studies immunogenicity of human primary bile duct organoids to be used as allogeneic cellular therapy for biliary diseases. Her research aims to understand their mechanisms of immune rejection and to develop strategies to enhance cellular engraftment and long-term survival using in vitro co-culture systems, genetic engineering, spatial transcriptomics and humanised mouse models.

Additionally, Sandra leads the multi-tissue organoid experimental platform at Avatrial Ltd (Milner Institute, Cambridge, UK), which is being integrated in the company’s multiomic data-driven pipeline for drug screening in oncology applications.

Speaker 2: Dr Mie Wong (University College London, Cell & Developmental Biology)

Title: to be confirmed